Igal Rosenstein (I Rosenstein)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Disease Activity

Molecularly Imprinted

Cerebrospinal Fluid

Multiple Sclerosis

Top Venues

Journal of neurology

Multiple sclerosis (Houndmills, Basingstoke, England)

Journal of neurology, neurosurgery, and psychiatry

Journal of neurochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Igal Rosenstein, Anna Nordin, Hemin Sabir, Clas Malmeström, Kaj Blennow, Markus Axelsson, Lenka Novakova
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis. Journal of neurology 271 (7) (2024)
Magnus Johnsson, Y T Stenberg, H H Farman, K Blennow, H Zetterberg, C Malmeström, Sofia Sandgren, Igal Rosenstein, Jan N Lycke, M Axelsson, Lenka Novakova
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (6) (2024)
Magnus Johnsson, Y T Stenberg, H H Farman, K Blennow, H Zetterberg, C Malmeström, Sofia Sandgren, Igal Rosenstein, Jan N Lycke, M Axelsson, Lenka Novakova
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (6) (2024)
Igal Rosenstein, Anna Nordin, Hemin Sabir, Clas Malmeström, Kaj Blennow, Markus Axelsson, Lenka Novakova
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis. Journal of neurology 271 (7) (2024)
Igal Rosenstein, Anna Nordin, Hemin Sabir, Clas Malmeström, Kaj Blennow, Markus Axelsson, Lenka Novakova
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis. Journal of neurology (2024)
Igal Rosenstein, Anna Nordin, Hemin Sabir, Clas Malmeström, Kaj Blennow, Markus Axelsson, Lenka Novakova
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis. Journal of neurology 271 (7) (2024)
Igal Rosenstein, Anna Nordin, Hemin Sabir, Clas Malmeström, Kaj Blennow, Markus Axelsson, Lenka Novakova
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis. Journal of neurology 271 (7) (2024)
Magnus Johnsson, Y T Stenberg, H H Farman, K Blennow, H Zetterberg, C Malmeström, Sofia Sandgren, Igal Rosenstein, Jan N Lycke, M Axelsson, Lenka Novakova
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (6) (2024)
Magnus Johnsson, Y T Stenberg, H H Farman, K Blennow, H Zetterberg, C Malmeström, Sofia Sandgren, Igal Rosenstein, Jan N Lycke, M Axelsson, Lenka Novakova
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study. Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
Magnus Johnsson, Y T Stenberg, H H Farman, K Blennow, H Zetterberg, C Malmeström, Sofia Sandgren, Igal Rosenstein, Jan N Lycke, M Axelsson, Lenka Novakova
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (6) (2024)
Igal Rosenstein, Anna Nordin, Hemin Sabir, Clas Malmeström, Kaj Blennow, Markus Axelsson, Lenka Novakova
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis. Journal of neurology 271 (7) (2024)
Nicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, Neus Mongay-Ochoa, Andreu Vilaseca-Jolonch, Sara Llufriu, Yolanda Blanco, Harald Hegen, Klaus Berek, Francisco Perez-Miralles, Konrad Rejdak, Luisa M Villar, Enric Monreal, Roberto Álvarez-Lafuente, Onder K Soylu, Ahmed Abdelhak, Franziska Bachhuber, Hayrettin Tumani, Sergio Martínez-Yélamos, Antonio J Sánchez-López, Antonio García-Merino, Lucía Gutiérrez, Tamara Castillo Triviño, Jan N Lycke, Igal Rosenstein, Roberto Furlan, Massimo Filippi, Nieves Téllez, Lluís Ramió-Torrentà, Jan D Lünemann, Heinz Wiendl, Sara Eichau, Micheal Khalil, Jens Kuhle, Xavier Montalban, Manuel Comabella Lopez
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (2023)
Igal Rosenstein, Markus Axelsson, Lenka Novakova, Clas Malmeström, Kaj Blennow, Henrik Zetterberg, Jan Lycke
Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing-remitting multiple sclerosis. Journal of neurology (2023)
Igal Rosenstein, Oluf Andersen, Daniel Victor, Elisabet Englund, Tobias Granberg, Carola Hedberg-Oldfors, Katharina Jood, Yusran Ady Fitrah, Takeshi Ikeuchi, Virginija Danylaité Karrenbauer
Four Swedish cases of CSF1R-related leukoencephalopathy: Visualization of clinical phenotypes. Acta neurologica Scandinavica 145 (5) (2022)
Igal Rosenstein, Sofia Rasch, Markus Axelsson, Lenka Novakova, Kaj Blennow, Henrik Zetterberg, Jan Lycke
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation. Journal of neurochemistry 159 (3) (2021)
Igal Rosenstein, Markus Axelsson, Lenka Novakova, Kaj Blennow, Henrik Zetterberg, Jan N Lycke
Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study. Multiple sclerosis (Houndmills, Basingstoke, England) (2021)